Rapid Micro Biosystems FY 2025: revenue $33.6M, up 20%; diluted EPS −$1.05
- Form
- 10-K
- Filed
- Period
- Importance
- Notable
- Accession
- 0001380106-26-000034
Key figures from this report
These are the numbers Rapid Micro Biosystems reported for the year ended Dec 31, 2025, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.
- Revenue$33.6M+20% from $28.1M in FY 202410-K income statement, on EDGAR
- Net income−$47.1MAgainst −$46.9M in FY 202410-K income statement, on EDGAR
- Diluted EPS−$1.05Against −$1.08 in FY 202410-K income statement, on EDGAR
- Cash and cash equivalents$20.0M+18% from $16.9M in FY 2024Cash and equivalents only; the company page adds short-term investments.10-K balance sheet, on EDGAR
- Cash from operations−$31.1MAgainst −$44.2M in FY 202410-K cash flow statement, on EDGAR
Similar companies
Companies of similar size in SIC 3826 and related industry codes: the same peer list as the financial tables.
- Hurco Companies HURC public float $101M, Apr 30, 2025, over 18 months old
- Owlet OWLT public float $96M, Jun 30, 2025
- Seer SEER public float $114M, Dec 31, 2025
- Geospace Technologies GEOS public float $90M, Mar 31, 2025, over 18 months old
- Intest INTT public float $85M, Jun 30, 2025